HealthCare Global Enterprises Limited
Sembol: HCG.BO
BSE
360.1
INRBugünkü piyasa fiyatı
142.5224
F/K Oranı
-2.9066
PEG Oranı
50.16B
MRK Kapağı
- 0.00%
DIV Verimi
HealthCare Global Enterprises Limited (HCG-BO) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1746.2 | 2041.5 | 1657.3 | |||||||||
balance-sheet.row.short-term-investments | 0 | 292.3 | 66.4 | 1357.3 | |||||||||
balance-sheet.row.net-receivables | 0 | 3095.5 | 2428.1 | 2148 | |||||||||
balance-sheet.row.inventory | 0 | 382.9 | 299.7 | 211.1 | |||||||||
balance-sheet.row.other-current-assets | 0 | 339.2 | 216.8 | 224.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 5803.4 | 5023.4 | 4349.6 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 13712.7 | 13577.9 | 12945.6 | |||||||||
balance-sheet.row.goodwill | 0 | 1812.3 | 1812.7 | 963.4 | |||||||||
balance-sheet.row.intangible-assets | 0 | 186.7 | 298 | 214.9 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1999.1 | 2110.7 | 1178.3 | |||||||||
balance-sheet.row.long-term-investments | 0 | 248 | 257.3 | 875.9 | |||||||||
balance-sheet.row.tax-assets | 0 | 52.7 | 59.6 | 343.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 1344.3 | 1166.4 | 663.6 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 17356.8 | 17171.9 | 16006.5 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.account-payables | 0 | 2484.5 | 1939.4 | 1455.2 | |||||||||
balance-sheet.row.short-term-debt | 0 | 864 | 859 | 1624.2 | |||||||||
balance-sheet.row.tax-payables | 0 | 24.7 | 5.3 | 3.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 8148 | 8287.8 | 8154.9 | |||||||||
Deferred Revenue Non Current | 0 | 359.3 | 255 | 279.8 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 2113.2 | 1604.6 | 1351.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8762.8 | 8660.6 | 8563.7 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5018.6 | 5070.4 | 5058.2 | |||||||||
balance-sheet.row.total-liab | 0 | 14466 | 13358.1 | 13216.1 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 1391.2 | 1390.1 | 1253.6 | |||||||||
balance-sheet.row.retained-earnings | 0 | -4522.4 | -4365.5 | -4751 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 13040 | 13019.1 | 11228.1 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -1303.5 | -1340.9 | -758.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 8605.2 | 8702.9 | 6971.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.minority-interest | 0 | 88.9 | 134.3 | 168.2 | |||||||||
balance-sheet.row.total-equity | 0 | 8694.2 | 8837.1 | 7140 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 226.6 | 249.5 | 388.5 | |||||||||
balance-sheet.row.total-debt | 0 | 9012 | 9146.8 | 9779 | |||||||||
balance-sheet.row.net-debt | 0 | 7265.8 | 7171.7 | 9479 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -33.5 | -65.9 | 486.5 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 65.1 | 31 | 19.1 | |||||||||
cash-flows.row.change-in-working-capital | 0 | -458.7 | -105.2 | -507.1 | |||||||||
cash-flows.row.account-receivables | 0 | -785.5 | -404.4 | -78.5 | |||||||||
cash-flows.row.inventory | 0 | -83.1 | -60.8 | 21.5 | |||||||||
cash-flows.row.account-payables | 0 | 563.5 | 442.9 | -528.9 | |||||||||
cash-flows.row.other-working-capital | 0 | -153.5 | -83 | 78.8 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 859.4 | -119.3 | 1901.2 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.acquisitions-net | 0 | 55.6 | 379.9 | -52.5 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -634.1 | -824 | -2883.6 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 501.9 | 2278 | 1515.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 124.3 | 63.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1330.3 | 1245.9 | -1711 | |||||||||
cash-flows.row.debt-repayment | 0 | -627.6 | -3455.6 | -2631.7 | |||||||||
cash-flows.row.common-stock-issued | 0 | 8.9 | 1321.6 | 5194.4 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-financing-activites | 0 | -782 | 585.1 | -1440.2 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1400.7 | -1548.8 | 1122.4 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -215.1 | 1898.3 | 616.6 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1711.8 | 1926.9 | 28.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1926.9 | 28.6 | -587.9 | |||||||||
cash-flows.row.operating-cash-flow | 0 | 2515.9 | 2201.2 | 1205.2 | |||||||||
cash-flows.row.capital-expenditure | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.free-cash-flow | 0 | 1183.5 | 1488.9 | 851 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 16760.5 | 13831.4 | 10040.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 7997.6 | 6820.7 | 4998.5 | |||||||||
income-statement-row.row.gross-profit | 0 | 8762.9 | 7010.6 | 5041.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.operating-expenses | 0 | 7109.6 | 6236.2 | 5367.4 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 15107.2 | 13056.9 | 10366 | |||||||||
income-statement-row.row.interest-income | 0 | 118.1 | 115.6 | 156.1 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 1653.2 | 788.4 | -368.4 | |||||||||
income-statement-row.row.income-before-tax | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 272.5 | 488.5 | -75.6 | |||||||||
income-statement-row.row.net-income | 0 | 293.5 | 537.3 | -1934.6 |
Sıkça Sorulan Sorular
Nedir HealthCare Global Enterprises Limited (HCG.BO) toplam varlıklar?
HealthCare Global Enterprises Limited (HCG.BO) toplam varlıklar 23160170000.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.517'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 2.531'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.019'dir.
Firma toplam geliri nedir?
Toplam gelir 0.076'dur.
Nedir HealthCare Global Enterprises Limited (HCG.BO) net kar (net gelir)?
Net kar (net gelir) 293490000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 9011980000.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 7109640000.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.